About
Technology
Issues
FAQ
Links
Official Page
Erythropoiesis‐Stimulating Agent Use for Anemia Induced by Interferon‐Ribavirin Treatment in Patients with Hepatitis C Virus Infection Is Not Associated with Increased Rates of Cardiovascular Disease, Thrombosis, Malignancy, or Death
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.